| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |